Camelia Ancuta

Mrs. Camelia Ancuta

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
EPEva Pozsgai
Eva Pozsgai
CBCsilla Busa
Csilla Busa
HBHolger Brunsch
Holger Brunsch
MEMichael Van der Elst
Michael Van der Elst
SPSheila Alison Payne
Sheila Alison Payne
ÁCÁgnes Csikós
Ágnes Csikós
Background/Objectives: Studies have shown that healthcare providers struggle to discuss difficult end-of-life issues, including palliative sedation (PS), with patients and relatives. This qualitative study aimed to evaluate communication challenges related to PS among healthcare providers in eight European countries. Methods: In each country, two clinical settings providing palliative care were selected. Two moral case deliberation (MCD) sessions were conducted, each with 3 to 9 palliative healthcare professionals (HCPs). They discussed patient cases involving PS and refractory symptom management. Sessions were audio-recorded, transcribed, anonymized, and analyzed using a framework analysis. Results: Key issues included core communication values—open, empathetic, and honest dialogue—which were consistent across countries but varied in practice. In The Netherlands, Germany, Belgium, and the UK, communication prioritized patient autonomy through timely discussions and family dialogue. In Spain and Italy, family-centered communication approaches predominated, while in Romania and Hungary, tendencies for selective disclosure were also evident, along with delegated decision-making and complex family dynamics. Certain challenges reflected professional experience rather than national culture. Nurses mediated across contexts, while terminology surrounding palliative sedation remained a source of ambiguity. Conclusions: This is the first study to present HCPs’ perceptions of communication issues related to PS across Europe. Despite variations between settings, consistently open dialogue among patients, families, and HCPs emerged as the most valued element. These findings highlight the need to better understand how end-of-life communication about PS varies in practice and underscore the importance of considering healthcare providers’ real-world experiences to improve communication with patients and families.

1 September 2025 in American Journal of Therapeutics
Verified
Journal Article
Closed access
CACamelia Ancuta
Camelia Ancuta
SPSandra Martins Pereira
Sandra Martins Pereira
LRLiliana Rogozea
Liliana Rogozea
NMNicoleta Mitrea
Nicoleta Mitrea
CCCodrina Csesznek
Codrina Csesznek
DMDaniela Mosoiu
Daniela Mosoiu
Background: The patterns of care for patients with advanced cancer in the last week of life are critical for ensuring quality and dignity during a vulnerable time. As patients approach end of life, the focus typically shifts from aggressive treatment to palliative care, emphasizing comfort and symptom management. The term “non-comfortoriented care” describes a set of medical interventions and treatments that prioritize prolonging life. This can lead to increased physical discomfort, emotional burden, or reduced quality of life. Areas of Uncertainty: For those who die in a medical setting, end-of-life care practices vary greatly and the care can be either comfort-oriented or noncomfort-oriented. There is a need for a clear overview of patterns for end-of-life care for patients with advanced cancer. Data Sources: Based on Whittemore's integrative review method, comprehensive searches were conducted in PubMed, Science Direct, Scopus, and Google Scholar databases. Population/Patient, Exposure, and Outcome format was used to formulate a research review question. Therapeutics Advances: Twenty-four articles were included. The key components of the patterns of care implemented during the last week of life are settings, palliative care involvement, intensity of therapeutics interventions, duration, and planning in advance. The only setting where solely comfort-oriented care was delivered was the community. In hospital settings, both comfort and noncomfort-oriented care were offered. Palliative care involvement was associated with comfort-oriented care, early recognition of dying (median 6 days), medication rationalizing, and implementation of care pathways. Noncomfort-oriented care patterns occurred in emergency departments, oncology, and general wards in acute hospitals with late recognition of dying (median 2 days) and use of inappropriate therapeutics interventions. Conclusion: To deliver the best care in the last week of life, new strategies are necessary to guide the clinical practices and to ensure patient-centered care.

17 September 2026 in Medicina
Verified
Journal Article
Open access
PDF file
CACamelia Ancuta
Camelia Ancuta
NMNicoleta Mitrea
Nicoleta Mitrea
MSMariana Sporis
Mariana Sporis
FHFlavia Hurducas
Flavia Hurducas
DMDaniela Mosoiu
Daniela Mosoiu
Background and Objectives: End-of-life care in oncology demands a holistic, multidisciplinary framework that pivots clinical priorities from disease-directed therapies toward symptom optimization, comfort, and patient dignity. Within this context, the present study investigated care delivery patterns among advanced cancer patients during their final week of life. Materials and Methods: A retrospective medical record review was conducted, comparing an oncology ward, an intensive care unit, an inpatient palliative unit, and a home-based palliative care setting. We analyzed aggressive interventions, end-of-life care pathways, symptom management, medication use and rationalization, and transitions between care settings. Results: Among the 306 patients studied, diagnostic testing and artificial hydration were universally administered in the oncology and intensive care unit (p < 0.001), where prescriptions focused primarily on pain management. Conversely, palliative care settings addressed a wider range of terminal symptoms. The rationalization of non-essential medications took place between 1.8 and 2.9 days before death, varying significantly across medication classes and clinical settings (p < 0.001). Additionally, intensive care unit admissions were more prevalent among patients with advanced cancer, while home-based patients underwent the greatest number of care transitions. Conclusions: These findings highlight substantial differences in care across settings, emphasizing the need for coordinated planning, continuity, and patient-centered approaches to ensure comfort and dignity in the final week of life.

8 September 2025 in BRAIN. BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE
Verified
Journal Article
Open access
PDF file
CACamelia Ancuta
Camelia Ancuta
ACAnamaria Ciubara
Anamaria Ciubara
DMDaniela Mosoiu
Daniela Mosoiu
Neuropsychiatric symptoms such as delirium, anxiety, depression, and agitation are prevalent among cancer patients at the end of life, significantly impacting quality of life for both patients and caregivers. Despite their clinical importance, these symptoms are often underrecognised and undertreated. This study aims to assess the frequency of neuropsychiatric symptoms and use of psychotropics in the last week of life in patients with advanced cancer. We conducted a retrospective review of medical records from adult cancer patients who died between January 1, 2024 and September 31, 2024, at Hospice Casa Sperantei and County Emergency Hospital of Brasov, Romania. Data collected included demographic information, documented neuropsychiatric symptoms, and psychotropic prescriptions in the last week of life. Descriptive statistics and subgroup analyses were used to assess symptom prevalence and prescribing trends. Among 305 patients included in the analysis, 70 (23%) had delirium, 55 (18%) had confusion, and 50 (16.4%) had insomnia. The main risk factors for delirium were nausea and constipation. The most used psychotropics in the last week of life were Haloperidol, Midazolam, and Lorazepam, but the patterns of prescribing varied by care setting. These findings highlight the need for improved recognition and management of psychiatric symptoms in palliative care, as well as the development of evidence-based prescribing guidelines to support appropriate and effective psychotropic use in this vulnerable population.